APO Research, Inc.

APO RESEARCH · REPORT

Azithromycin Drug

Selected research

Market Structure

Global Azithromycin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Azithromycin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azithromycin Drug include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azithromycin Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azithromycin Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azithromycin Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azithromycin Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Azithromycin Drug Segment by Company

Teva

Sandoz

Mylan

Pfizer

Hainan Poly Pharm

Hainan Hailing Chemipharma Corporation

Zydus Pharmaceuticals

Wockhardt

PLIVA

Lupin

Gland Pharma Limited

CSPC Ouyi Pharmaceutical

CSPC

Aurobindo Pharma

Akorn

Azithromycin Drug Segment by Type

Oral

Injection

Azithromycin Drug Segment by Application

Hospital

Drug Store

Azithromycin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azithromycin Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Azithromycin Drug Industry Trends Table 2. Azithromycin Drug Industry Drivers Table 3. Azithromycin Drug Industry Opportunities and Challenges Table 4. Azithromycin Drug Industry Restraints Table 5. Global Azithromycin Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Azithromycin Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Azithromycin Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Azithromycin Drug Sales Market Share by Manufacturers Table 9. Global Azithromycin Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Azithromycin Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Azithromycin Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Azithromycin Drug Manufacturers, Product Type & Application Table 13. Global Azithromycin Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Azithromycin Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Azithromycin Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Azithromycin Drug Sales by Type (2021-2026) & (W Units) Table 20. Global Azithromycin Drug Sales by Type (2027-2032) & (W Units) Table 21. Global Azithromycin Drug Sales Market Share by Type (2021-2026) Table 22. Global Azithromycin Drug Sales Market Share by Type (2027-2032) Table 23. Global Azithromycin Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Azithromycin Drug Revenue by Type (2021-2026) & (W Units) Table 25. Global Azithromycin Drug Revenue by Type (2027-2032) & (W Units) Table 26. Global Azithromycin Drug Revenue Market Share by Type (2021-2026) Table 27. Global Azithromycin Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Global Azithromycin Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 31. Global Azithromycin Drug Sales by Application (2021-2026) & (W Units) Table 32. Global Azithromycin Drug Sales by Application (2027-2032) & (W Units) Table 33. Global Azithromycin Drug Sales Market Share by Application (2021-2026) Table 34. Global Azithromycin Drug Sales Market Share by Application (2027-2032) Table 35. Global Azithromycin Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Azithromycin Drug Revenue by Application (2021-2026) & (W Units) Table 37. Global Azithromycin Drug Revenue by Application (2027-2032) & (W Units) Table 38. Global Azithromycin Drug Revenue Market Share by Application (2021-2026) Table 39. Global Azithromycin Drug Revenue Market Share by Application (2027-2032) Table 40. Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 41. Global Azithromycin Drug Sales by Region (2021-2026) & (W Units) Table 42. Global Azithromycin Drug Sales Market Share by Region (2021-2026) Table 43. Global Azithromycin Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 44. Global Azithromycin Drug Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 46. North America Azithromycin Drug Sales by Country (2021-2026) & (W Units) Table 47. North America Azithromycin Drug Sales by Country (2027-2032) & (W Units) Table 48. Europe Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. Europe Azithromycin Drug Sales by Country (2021-2026) & (W Units) Table 50. Europe Azithromycin Drug Sales by Country (2027-2032) & (W Units) Table 51. Asia Pacific Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Asia Pacific Azithromycin Drug Sales by Country (2021-2026) & (W Units) Table 53. Asia Pacific Azithromycin Drug Sales by Country (2027-2032) & (W Units) Table 54. South America, Middle East and Africa Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. South America, Middle East and Africa Azithromycin Drug Sales by Country (2021-2026) & (W Units) Table 56. South America, Middle East and Africa Azithromycin Drug Sales by Country (2027-2032) & (W Units) Table 57. Global Azithromycin Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Azithromycin Drug Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Azithromycin Drug Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Azithromycin Drug Revenue Market Share by Region (2021-2026) Table 61. Global Azithromycin Drug Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Azithromycin Drug Product Portfolio Table 66. Teva Recent Development Table 67. Sandoz Company Information Table 68. Sandoz Business Overview Table 69. Sandoz Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sandoz Azithromycin Drug Product Portfolio Table 71. Sandoz Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mylan Azithromycin Drug Product Portfolio Table 76. Mylan Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Azithromycin Drug Product Portfolio Table 81. Pfizer Recent Development Table 82. Hainan Poly Pharm Company Information Table 83. Hainan Poly Pharm Business Overview Table 84. Hainan Poly Pharm Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hainan Poly Pharm Azithromycin Drug Product Portfolio Table 86. Hainan Poly Pharm Recent Development Table 87. Hainan Hailing Chemipharma Corporation Company Information Table 88. Hainan Hailing Chemipharma Corporation Business Overview Table 89. Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio Table 91. Hainan Hailing Chemipharma Corporation Recent Development Table 92. Zydus Pharmaceuticals Company Information Table 93. Zydus Pharmaceuticals Business Overview Table 94. Zydus Pharmaceuticals Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Zydus Pharmaceuticals Azithromycin Drug Product Portfolio Table 96. Zydus Pharmaceuticals Recent Development Table 97. Wockhardt Company Information Table 98. Wockhardt Business Overview Table 99. Wockhardt Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Wockhardt Azithromycin Drug Product Portfolio Table 101. Wockhardt Recent Development Table 102. PLIVA Company Information Table 103. PLIVA Business Overview Table 104. PLIVA Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. PLIVA Azithromycin Drug Product Portfolio Table 106. PLIVA Recent Development Table 107. Lupin Company Information Table 108. Lupin Business Overview Table 109. Lupin Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Lupin Azithromycin Drug Product Portfolio Table 111. Lupin Recent Development Table 112. Gland Pharma Limited Company Information Table 113. Gland Pharma Limited Business Overview Table 114. Gland Pharma Limited Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Gland Pharma Limited Azithromycin Drug Product Portfolio Table 116. Gland Pharma Limited Recent Development Table 117. CSPC Ouyi Pharmaceutical Company Information Table 118. CSPC Ouyi Pharmaceutical Business Overview Table 119. CSPC Ouyi Pharmaceutical Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio Table 121. CSPC Ouyi Pharmaceutical Recent Development Table 122. CSPC Company Information Table 123. CSPC Business Overview Table 124. CSPC Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. CSPC Azithromycin Drug Product Portfolio Table 126. CSPC Recent Development Table 127. Aurobindo Pharma Company Information Table 128. Aurobindo Pharma Business Overview Table 129. Aurobindo Pharma Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Aurobindo Pharma Azithromycin Drug Product Portfolio Table 131. Aurobindo Pharma Recent Development Table 132. Akorn Company Information Table 133. Akorn Business Overview Table 134. Akorn Azithromycin Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Akorn Azithromycin Drug Product Portfolio Table 136. Akorn Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Azithromycin Drug Distributors List Table 140. Azithromycin Drug Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Azithromycin Drug Product Image Figure 2. Global Azithromycin Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azithromycin Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Azithromycin Drug Sales (2021-2032) & (W Units) Figure 5. Global Azithromycin Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Azithromycin Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Azithromycin Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Azithromycin Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Azithromycin Drug Sales Market Share by Type (2021-2032) Figure 13. Global Azithromycin Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Azithromycin Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Azithromycin Drug Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Global Azithromycin Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Azithromycin Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Azithromycin Drug Sales Market Share by Application (2021-2032) Figure 21. Global Azithromycin Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Azithromycin Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Azithromycin Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 25. North America Azithromycin Drug Sales Market Share by Country (2021-2032) Figure 26. U.S. Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 27. Canada Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Mexico Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Europe Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Azithromycin Drug Sales Market Share by Country (2021-2032) Figure 31. Germany Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. France Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. U.K. Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Italy Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Netherlands Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Asia Pacific Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Azithromycin Drug Sales Market Share by Country (2021-2032) Figure 38. China Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Japan Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. South Korea Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Southeast Asia Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. India Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Australia Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South America, Middle East and Africa Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Azithromycin Drug Sales Market Share by Country (2021-2032) Figure 46. Brazil Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Africa Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Saudi Arabia Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Turkey Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Argentina Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. UAE Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Egypt Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Chile Azithromycin Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Global Azithromycin Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Azithromycin Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Azithromycin Drug Revenue (2021-2032) & (US$ Million) Figure 57. North America Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Azithromycin Drug Revenue (2021-2032) & (US$ Million) Figure 59. Europe Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Azithromycin Drug Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Azithromycin Drug Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Azithromycin Drug Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Azithromycin Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Pfizer
  • Hainan Poly Pharm
  • Hainan Hailing Chemipharma Corporation
  • Zydus Pharmaceuticals
  • Wockhardt
  • PLIVA
  • Lupin
  • Gland Pharma Limited
  • CSPC Ouyi Pharmaceutical
  • CSPC
  • Aurobindo Pharma
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Azithromycin Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Azithromycin Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Azithromycin Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Azithromycin Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Azithromycin Drug Market Dynamics
  1. 2.1 Azithromycin Drug Industry Trends
  2. 2.2 Azithromycin Drug Industry Drivers
  3. 2.3 Azithromycin Drug Industry Opportunities and Challenges
  4. 2.4 Azithromycin Drug Industry Restraints
3 Azithromycin Drug Market by Manufacturers
  1. 3.1 Global Azithromycin Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Azithromycin Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Azithromycin Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Azithromycin Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azithromycin Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Azithromycin Drug Manufacturers, Product Type & Application
  7. 3.7 Global Azithromycin Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azithromycin Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azithromycin Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azithromycin Drug Tier 1, Tier 2, and Tier 3
4 Azithromycin Drug Market by Type
  1. 4.1 Azithromycin Drug Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Azithromycin Drug Sales by Type
  5. 4.2.1 Global Azithromycin Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Azithromycin Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Azithromycin Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Azithromycin Drug Revenue by Type
  9. 4.3.1 Global Azithromycin Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Azithromycin Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Azithromycin Drug Revenue Market Share by Type (2021-2032)
5 Azithromycin Drug Market by Application
  1. 5.1 Azithromycin Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Azithromycin Drug Sales by Application
  5. 5.2.1 Global Azithromycin Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Azithromycin Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Azithromycin Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Azithromycin Drug Revenue by Application
  9. 5.3.1 Global Azithromycin Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Azithromycin Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Azithromycin Drug Revenue Market Share by Application (2021-2032)
6 Global Azithromycin Drug Sales by Region
  1. 6.1 Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azithromycin Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Azithromycin Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Azithromycin Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Azithromycin Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Azithromycin Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Azithromycin Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Azithromycin Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Azithromycin Drug Revenue by Region
  1. 7.1 Global Azithromycin Drug Revenue by Region
  2. 7.1.1 Global Azithromycin Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Azithromycin Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Azithromycin Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Azithromycin Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Azithromycin Drug Revenue (2021-2032)
  8. 7.2.2 North America Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Azithromycin Drug Revenue (2021-2032)
  11. 7.3.2 Europe Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Azithromycin Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Azithromycin Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Azithromycin Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Azithromycin Drug Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Azithromycin Drug Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Azithromycin Drug Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Hainan Poly Pharm
  26. 8.5.1 Hainan Poly Pharm Company Information
  27. 8.5.2 Hainan Poly Pharm Business Overview
  28. 8.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
  30. 8.5.5 Hainan Poly Pharm Recent Developments
  31. 8.6 Hainan Hailing Chemipharma Corporation
  32. 8.6.1 Hainan Hailing Chemipharma Corporation Company Information
  33. 8.6.2 Hainan Hailing Chemipharma Corporation Business Overview
  34. 8.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
  36. 8.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
  37. 8.7 Zydus Pharmaceuticals
  38. 8.7.1 Zydus Pharmaceuticals Company Information
  39. 8.7.2 Zydus Pharmaceuticals Business Overview
  40. 8.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
  42. 8.7.5 Zydus Pharmaceuticals Recent Developments
  43. 8.8 Wockhardt
  44. 8.8.1 Wockhardt Company Information
  45. 8.8.2 Wockhardt Business Overview
  46. 8.8.3 Wockhardt Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Wockhardt Azithromycin Drug Product Portfolio
  48. 8.8.5 Wockhardt Recent Developments
  49. 8.9 PLIVA
  50. 8.9.1 PLIVA Company Information
  51. 8.9.2 PLIVA Business Overview
  52. 8.9.3 PLIVA Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PLIVA Azithromycin Drug Product Portfolio
  54. 8.9.5 PLIVA Recent Developments
  55. 8.10 Lupin
  56. 8.10.1 Lupin Company Information
  57. 8.10.2 Lupin Business Overview
  58. 8.10.3 Lupin Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lupin Azithromycin Drug Product Portfolio
  60. 8.10.5 Lupin Recent Developments
  61. 8.11 Gland Pharma Limited
  62. 8.11.1 Gland Pharma Limited Company Information
  63. 8.11.2 Gland Pharma Limited Business Overview
  64. 8.11.3 Gland Pharma Limited Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
  66. 8.11.5 Gland Pharma Limited Recent Developments
  67. 8.12 CSPC Ouyi Pharmaceutical
  68. 8.12.1 CSPC Ouyi Pharmaceutical Company Information
  69. 8.12.2 CSPC Ouyi Pharmaceutical Business Overview
  70. 8.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
  72. 8.12.5 CSPC Ouyi Pharmaceutical Recent Developments
  73. 8.13 CSPC
  74. 8.13.1 CSPC Company Information
  75. 8.13.2 CSPC Business Overview
  76. 8.13.3 CSPC Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CSPC Azithromycin Drug Product Portfolio
  78. 8.13.5 CSPC Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Azithromycin Drug Product Portfolio
  90. 8.15.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azithromycin Drug Value Chain Analysis
  2. 9.1.1 Azithromycin Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azithromycin Drug Production Mode & Process
  6. 9.2 Azithromycin Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azithromycin Drug Distributors
  9. 9.2.3 Azithromycin Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.